ESG + Liraglutide (Saxenda): nice proof-of-concept from @jhmweightloss @MPGN46 with 12-month weight loss superior with additional of meds (24.7% vs 20.5%). Though retrospective and non-randomized, these findings highlight the potential of combo therapy. https://t.co/KeEETW49aw
Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2020 – Nov 2023Where it's discussed
-
X / Twitter9 posts
-
YouTube2 videos
-
News2 articles
AI synopsis
What people are saying
Discussions highlight the promising results of combining endoscopic procedures with medication, using phrases like 'proof-of-concept' and 'superior weight loss.' The tone reflects curiosity and optimism about the future of combined therapies, with references to ongoing studies and previous research, indicating active engagement and perceived significance.
Most discussions support the positive findings of the study, emphasizing the effectiveness of combining therapies for weight loss.
The topic clearly piques interest, with many comments mentioning ongoing research and future potential.
Discussions reference specific research methods and results, indicating active engagement with the content.
The conversations suggest that this research could influence future treatment approaches and clinical practices.
Abstract in brief
- This study compares two groups of patients: those who had endoscopic sleeve gastroplasty (ESG) combined with liraglutide (a medication to help with weight loss) versus those who had ESG alone, to see which method is more effective for weight loss and reducing body fat.
- Results showed that patients taking liraglutide after ESG experienced greater overall weight loss and body fat reduction after 7 and 12 months compared to those who only had ESG.
- The findings suggest that adding liraglutide to ESG enhances weight loss outcomes, but further research is needed to determine the best timing and dosage for the medication.]
Top posts
Most liked on X and Bluesky@Ali_Aminian_MD @OMGhanemMD @AbdTahrani @TheLancet @drbutsch @DanielJDrucker @MetabolicEndo @ASMBS @carel_leroux @ProfBatterhamMD @DrRobertKushner @AniaJastreboff @rachelmooremd Combination therapies together or in sequence is definitely the future. We have an ongoing RCT. See previous propensity score adjusted study DOI: 10.1016/j.gie.2020.10.016
Badurdeen et al explore the use of “Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss” in their new article. https://t.co/Gs3dHdL6Gc https://t.co/lG7z0SkZMk
Drs Mohamad Itani, Anna Carolina Hoff, and Dilhana Badurdeen discuss their article, "Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss" from the June issue. https://t.co/5PLfaJbEjx
RT @GIE_Journal: Badurdeen et al explore the use of “Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty…
RT @DrMcGowanMD: ESG + Liraglutide (Saxenda): nice proof-of-concept from @jhmweightloss @MPGN46 with 12-month weight loss superior with add…
All mentions
Enhanced Weight Loss with Endoscopic Sleeve Gastroplasty and Liraglutide
Drs Mohamad Itani, Anna Carolina Hoff, and Dilhana Badurdeen discuss their study comparing endoscopic sleeve gastroplasty combined with liraglutide versus gastroplasty alone for weight loss, highlighting improved…
Enhanced Weight Loss with Semaglutide and Endoscopic Sleeve Gastroplasty
New research presented at Digestive Disease Week 2021 indicates that GLP1 semaglutide combined with endoscopic sleeve gastroplasty (ESG) improves weight loss outcomes, bringing results closer to laparoscopic sleeve…
@Ali_Aminian_MD @OMGhanemMD @AbdTahrani @TheLancet @drbutsch @DanielJDrucker @MetabolicEndo @ASMBS @carel_leroux @ProfBatterhamMD @DrRobertKushner @AniaJastreboff @rachelmooremd Combination therapies together or in sequence is definitely the future. We have an ongoing RCT. See previous propensity score adjusted study DOI: 10.1016/j.gie.2020.10.016
RT @GIE_Journal: Badurdeen et al explore the use of “Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty…
RT @GIE_Journal: Badurdeen et al explore the use of “Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty…
Badurdeen et al explore the use of “Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss” in their new article. https://t.co/Gs3dHdL6Gc https://t.co/lG7z0SkZMk
Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss https://t.co/wldPOoD0QT
Drs Mohamad Itani, Anna Carolina Hoff, and Dilhana Badurdeen discuss their article, "Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss" from the June issue. https://t.co/5PLfaJbEjx
RT @DrMcGowanMD: ESG + Liraglutide (Saxenda): nice proof-of-concept from @jhmweightloss @MPGN46 with 12-month weight loss superior with add…
RT @DrMcGowanMD: ESG + Liraglutide (Saxenda): nice proof-of-concept from @jhmweightloss @MPGN46 with 12-month weight loss superior with add…
ESG + Liraglutide (Saxenda): nice proof-of-concept from @jhmweightloss @MPGN46 with 12-month weight loss superior with additional of meds (24.7% vs 20.5%). Though retrospective and non-randomized, these findings highlight the potential of combo therapy. https://t.co/KeEETW49aw
CM
BF
G
S
PM
MM
DP
MI